APO RESEARCH · REPORT
Erythropoietin
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Product & engineering
Understand the product.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.
In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml
Selected research
Industry Research
Erythropoietin Industry Research Report 2026
Market perspective
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.
In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml
Read the full market overview
The major players in global Erythropoietin market include Amgen, Johnson & Johnson, etc. The top 2 players occupy about 60% shares of the global market. North America is the main market, and occupies over 65% of the global market. Epoetin-alfa is the main type, with a share about 80%. Kidney Disorders is the key application, which holds a share over 40%.
Report Scope
This report quantifies the global Erythropoietin market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Erythropoietin Market by Company
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Erythropoietin Segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
Erythropoietin Segment by Application
Anemia
Kidney Disorders
Others
Erythropoietin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erythropoietin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Erythropoietin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erythropoietin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Erythropoietin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Erythropoietin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Erythropoietin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Epoetin-alfa
- Epoetin-beta
- Darbepoetin-alfa
- Others
Applications
- Anemia
- Kidney Disorders
- Others
Companies covered
- Amgen
- Johnson & Johnson
- Roche
- Galenica
- Emcure
- Kyowa Hakko Kirin
- 3SBio
- Biocon
- LG Life Sciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Erythropoietin Market Size (2021-2032)
- 2.2.2 Global Erythropoietin Sales (2021-2032)
- 2.2.3 Global Erythropoietin Market Average Price (2021-2032)
- 2.3 Erythropoietin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Epoetin-alfa
- 2.3.3 Epoetin-beta
- 2.3.4 Darbepoetin-alfa
- 2.3.5 Others
- 2.4 Erythropoietin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Anemia
- 2.4.3 Kidney Disorders
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Erythropoietin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Erythropoietin Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Erythropoietin Revenue of Manufacturers (2021-2026)
- 3.4 Global Erythropoietin Average Price by Manufacturers (2021-2026)
- 3.5 Global Erythropoietin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Erythropoietin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Erythropoietin, Product Type & Application
- 3.8 Global Manufacturers of Erythropoietin, Established Date
- 3.9 Global Erythropoietin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Amgen
- 4.1.1 Amgen Company Information
- 4.1.2 Amgen Business Overview
- 4.1.3 Amgen Erythropoietin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Amgen Erythropoietin Product Portfolio
- 4.1.5 Amgen Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Erythropoietin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Erythropoietin Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Roche
- 4.3.1 Roche Company Information
- 4.3.2 Roche Business Overview
- 4.3.3 Roche Erythropoietin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roche Erythropoietin Product Portfolio
- 4.3.5 Roche Recent Developments
- 4.4 Galenica
- 4.4.1 Galenica Company Information
- 4.4.2 Galenica Business Overview
- 4.4.3 Galenica Erythropoietin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Galenica Erythropoietin Product Portfolio
- 4.4.5 Galenica Recent Developments
- 4.5 Emcure
- 4.5.1 Emcure Company Information
- 4.5.2 Emcure Business Overview
- 4.5.3 Emcure Erythropoietin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Emcure Erythropoietin Product Portfolio
- 4.5.5 Emcure Recent Developments
- 4.6 Kyowa Hakko Kirin
- 4.6.1 Kyowa Hakko Kirin Company Information
- 4.6.2 Kyowa Hakko Kirin Business Overview
- 4.6.3 Kyowa Hakko Kirin Erythropoietin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Kyowa Hakko Kirin Erythropoietin Product Portfolio
- 4.6.5 Kyowa Hakko Kirin Recent Developments
- 4.7 3SBio
- 4.7.1 3SBio Company Information
- 4.7.2 3SBio Business Overview
- 4.7.3 3SBio Erythropoietin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 3SBio Erythropoietin Product Portfolio
- 4.7.5 3SBio Recent Developments
- 4.8 Biocon
- 4.8.1 Biocon Company Information
- 4.8.2 Biocon Business Overview
- 4.8.3 Biocon Erythropoietin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Biocon Erythropoietin Product Portfolio
- 4.8.5 Biocon Recent Developments
- 4.9 LG Life Sciences
- 4.9.1 LG Life Sciences Company Information
- 4.9.2 LG Life Sciences Business Overview
- 4.9.3 LG Life Sciences Erythropoietin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 LG Life Sciences Erythropoietin Product Portfolio
- 4.9.5 LG Life Sciences Recent Developments
5 Global Erythropoietin Market Scenario by Region
- 5.1 Global Erythropoietin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Erythropoietin Sales by Region: 2021-2032
- 5.2.1 Global Erythropoietin Sales by Region: 2021-2026
- 5.2.2 Global Erythropoietin Sales by Region: 2027-2032
- 5.3 Global Erythropoietin Revenue by Region: 2021-2032
- 5.3.1 Global Erythropoietin Revenue by Region: 2021-2026
- 5.3.2 Global Erythropoietin Revenue by Region: 2027-2032
- 5.4 North America Erythropoietin Market Facts & Figures by Country
- 5.4.1 North America Erythropoietin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Erythropoietin Sales by Country (2021-2032)
- 5.4.3 North America Erythropoietin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Erythropoietin Market Facts & Figures by Country
- 5.5.1 Europe Erythropoietin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Erythropoietin Sales by Country (2021-2032)
- 5.5.3 Europe Erythropoietin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Erythropoietin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Erythropoietin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Erythropoietin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Erythropoietin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Erythropoietin Market Facts & Figures by Country
- 5.7.1 South America Erythropoietin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Erythropoietin Sales by Country (2021-2032)
- 5.7.3 South America Erythropoietin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Erythropoietin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Erythropoietin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Erythropoietin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Erythropoietin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Erythropoietin Sales by Type (2021-2032)
- 6.1.1 Global Erythropoietin Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Erythropoietin Sales Market Share by Type (2021-2032)
- 6.2 Global Erythropoietin Revenue by Type (2021-2032)
- 6.2.1 Global Erythropoietin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Erythropoietin Revenue Market Share by Type (2021-2032)
- 6.3 Global Erythropoietin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Erythropoietin Sales by Application (2021-2032)
- 7.1.1 Global Erythropoietin Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Erythropoietin Sales Market Share by Application (2021-2032)
- 7.2 Global Erythropoietin Revenue by Application (2021-2032)
- 7.2.1 Global Erythropoietin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Erythropoietin Revenue Market Share by Application (2021-2032)
- 7.3 Global Erythropoietin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Erythropoietin Value Chain Analysis
- 8.1.1 Erythropoietin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Erythropoietin Production Mode & Process
- 8.2 Erythropoietin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Erythropoietin Distributors
- 8.2.3 Erythropoietin Customers
9 Global Erythropoietin Analyzing Market Dynamics
- 9.1 Erythropoietin Industry Trends
- 9.2 Erythropoietin Industry Drivers
- 9.3 Erythropoietin Industry Opportunities and Challenges
- 9.4 Erythropoietin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst